Under what conditions is it ethical to offer incentives to encourage drug‐using women to use long‐acting forms of contraception?

Lucke, Jayne; Hall, Wayne

doi:10.1111/j.1360-0443.2011.03699.x

Cited by 40 publications

(38 citation statements)

References 44 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The 13 emergence of Project Prevention, a US-based initiative that aims to reduce the number of infants subject to illicit drug use by incentivising contraceptive uptake/sterilisation through financial rewards, has been subject to fierce opposition. Critics have argued that to offer of a sizeable and immediate financial incentive to individuals dependent on drugs is coercive (Lucke and Hall, 2011). Project prevent exploits the addict's vulnerability to short-term gratification, and does little to foster longer-term goals in respect of rehabilitation.…”

Section: Supporting Reproductive Autonomy?mentioning

confidence: 99%

See 1 more Smart Citation

Vulnerable birth mothers and repeat losses of infants to public care: is targeted reproductive health care ethically defensible?

Broadhurst

Shaw

Kershaw

et al. 2015

Journal of Social Welfare and Family Law

View full text Add to dashboard Cite

This article aims to advance debate about the ethics of targeted reproductive health care for birth mothers who have experienced recurrent care proceedings. Making reference to new research evidence that reports the scale of the problem of repeat care proceedings in England, the article considers the role that enhanced reproductive health care might play in helping mothers exit a cycle of care proceedings. Emerging practice initiatives are introduced which are all stretching the boundaries of statutory intervention, by working intensively with mothers following removal of children to public care. The central argument of this paper is that a positive interpretation of rights provides a warrant for providing enhanced access to contraception, but this must be part and parcel of a holistic, recovery focused approach to intervention.

show abstract

Section: Supporting Reproductive Autonomy?mentioning

confidence: 99%

“…The issue of unplanned pregnancy has been extensively discussed in the international literature in relation to socially disadvantaged women (Finer and Henshaw, 2006;Ryan et al, 2008;Lucke and Hall, 2011). Equally the health risks of short-interval pregnancies are evidenced (Zhu, 2005;Wendt et al, 2012).…”

Section: Introductionmentioning

confidence: 99%

Vulnerable birth mothers and repeat losses of infants to public care: is targeted reproductive health care ethically defensible?

Broadhurst

Shaw

Kershaw

et al. 2015

Journal of Social Welfare and Family Law

View full text Add to dashboard Cite

show abstract

“…In the former study, there were protocol violations in about 50% of the patients receiving t-PA as compared to 33% in the latter. Although in both the studies, protocol violations were not related to symptomatic ICH, other studies have shown that these events are indeed related to each other [11][12][13]. The safety and efficacy of administration of t-PA also was demonstrated by the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST) study [14].…”

Section: Review Articlementioning

confidence: 96%

A Review of Intra-arterial and Intravenous Therapies for Acute Ischemic Stroke: Relevance, Challenges and Developments

Gudlavalleti¹

2015

JNSK

View full text Add to dashboard Cite

Intravenous and intra-arterial thrombolysis (IVT and IAT, respectively) are the two major therapeutic options for management of acute ischemic stroke (AIS). However, the FDA has only approved IVT for management of AIS, when the patient presents within 0-4.5 hours of AIS onset. This recommendation was based on numerous randomized controlled trials (RCT) which, when analyzed together, showed a net benefit towards the use of IVT. But a narrow therapeutic window, which is rarely met by the individual, and the relative inefficacy of IVT in large artery occlusions, leaves a lot to be desired in the management of AIS. Thus, in these situations, the focus has shifted towards the possibility of using IAT, both pharmacologic and mechanical. Numerous studies have been performed comparing IAT and IVT in treating AIS. None of the major trials found any significant benefit of IAT when compared with IVT. In this review, we compare the efficacy and the relative benefits of both IAT and IVT and discuss the significant findings and limitations of major trials studying these therapies. We suggest that IAT appears as a promising alternative to IVT in specific cases. The lack of benefit observed in major RCTs may have been due to inadequate study designs and execution. Further randomized controlled trials are underway to better understand the role of IAT in AIS.

show abstract

“…Examples of incentivizing programs still effective in the U.S. today include ''Dollar-a-Day'' programs, encouraging adolescent women to delay procreation by paying them a dollar every day they do not get pregnant (Steinbock, 1996;Mills 1999), and programs like ''Project Prevention''-formerly, Children Requiring a Caring Kommunity (CRACK)-which offers three-hundred dollars to drug-addicted individuals (overwhelmingly women) who undergo sterilization or use LARCs (Lucke and Hall 2012). Undoubtedly, children of abusive or drug-addicted parents are vulnerable to devastating harms, and creative preventative solutions should be explored.…”

Section: Decreased Moral Standingmentioning

confidence: 99%

What is it to Share Contraceptive Responsibility?

Davis

2015

Topoi

View full text Add to dashboard Cite

There are three stages at which procreative outcomes can be prevented or altered: (1) prior to conception (2) during pregnancy and (3) after birth. Daniel Engster (Soc Theory Pract 36(2):233-262, 2010) has ably argued that plans to prevent or alter procreative outcomes at stages (2) and (3)-through abortion and adoptionintroduce financial, physical, and emotional hardships to which women are disproportionately vulnerable. In this paper, I argue that plans to prevent or alter undesirable procreative outcomes at stage (1)-through contraception use-similarly disadvantage women. I suggest that accounts proposing moral responsibilities to delay or permanently avoid procreation are insufficiently attentive to the methods through which undesirable procreative outcomes might be prevented and how such methods unfairly burden women. In conclusion, I propose several ways that men and women might more equitably share contraceptive responsibility.

show abstract

Under what conditions is it ethical to offer incentives to encourage drug‐using women to use long‐acting forms of contraception?

Abstract: We need more research on ways in which small non-cash incentives for reversible methods of contraception could be used in a morally acceptable and effective way to promote the sexual, reproductive and general health of addicted women.

Cited by 40 publications

References 44 publications

Vulnerable birth mothers and repeat losses of infants to public care: is targeted reproductive health care ethically defensible?

Vulnerable birth mothers and repeat losses of infants to public care: is targeted reproductive health care ethically defensible?

A Review of Intra-arterial and Intravenous Therapies for Acute Ischemic Stroke: Relevance, Challenges and Developments

What is it to Share Contraceptive Responsibility?

Contact Info

Product

Resources

About